Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Sun Pharmaceuticals Industries's Days Payable or its related term are showing as below:
BOM:524715'
s Days Payable Range Over the Past 10 Years
Min: 134.75 Med: 163.33 Max: 213.15
Current: 213.15
During the past 13 years, Sun Pharmaceuticals Industries's highest Days Payable was 213.15. The lowest was 134.75. And the median was 163.33.
BOM:524715's Days Payable is ranked better than 86.18% of 926
companies
in the Drug Manufacturers industry
Industry Median: 90.22
vs BOM:524715: 213.15
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharmaceuticals Industries's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sun Pharmaceuticals Industries Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sun Pharmaceuticals Industries's Days Payable distribution charts can be found below:
* The bar in red indicates where Sun Pharmaceuticals Industries's Days Payable falls into.
Sun Pharmaceuticals Industries Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sun Pharmaceuticals Industries (BOM:524715) has a Days Payable of 238.91 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sun Pharmaceuticals Industries and its competitors. This is 46% above median its historical median of 163.33. Over the past decade, Sun Pharmaceuticals Industries' Days Payable has ranged from 134.75 to 213.15. According to the industry distribution chart, Sun Pharmaceuticals Industries ranks #128 out of 926 companies in the Drug Manufacturers industry, placing it in the top 13.8%.
Is Sun Pharmaceuticals Industries' Days Payable too high?
Sun Pharmaceuticals Industries' current Days Payable of 238.91 is 46% above median its 10-year median of 163.33. Over the past 10 years, this metric has ranged from a low of 134.75 to a high of 213.15. The Drug Manufacturers industry median Days Payable is 90.22. Sun Pharmaceuticals Industries' value of 238.91 is 164.8% above this industry median. Based on the distribution chart, Sun Pharmaceuticals Industries ranks #128 out of 926 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sun Pharmaceuticals Industries has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sun Pharmaceuticals Industries' Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Sun Pharmaceuticals Industries ranks #128 out of 926 companies for Days Payable. This places Sun Pharmaceuticals Industries in the top 14% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.22. Sun Pharmaceuticals Industries' value of 238.91 is 164.8% above this benchmark. Historically, Sun Pharmaceuticals Industries' own Days Payable has ranged from 134.75 to 213.15 over the past decade. While the company's 10-year median is 163.33 vs. the industry median of 90.22, Sun Pharmaceuticals Industries has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.22, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sun Pharmaceuticals Industries's current Days Payable of 238.91 is 164.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sun Pharmaceuticals Industries and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sun Pharmaceuticals Industries's current Days Payable is 238.91, which is 46% above median its own 10-year median of 163.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sun Pharmaceuticals Industries stock overvalued right now?
Based on GuruFocus' analysis, Sun Pharmaceuticals Industries (BOM:524715) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,927.98, compared to a current price of ₹1,973.50 — trading 2.4% above its estimated fair value. The current Days Payable is 238.91, which is 46% above median its 10-year median of 163.33 and 164.8% above the Drug Manufacturers industry median of 90.22. Sun Pharmaceuticals Industries' overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sun Pharmaceuticals Industries (BOM:524715), the current Days Payable is 238.91 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sun Pharmaceuticals Industries (BOM:524715) Overvalued in 2026?
Based on GuruFocus' analysis, Sun Pharmaceuticals Industries stock appears to be overvalued.
The current stock price of ₹1,973.50 is trading 2.4% above its estimated GF Value™ of ₹1,927.98.
GuruFocus considers Sun Pharmaceuticals Industries to be Fairly Valued.
Key valuation signals for BOM:524715:
Days Payable: 238.91 (46% above median its 10-year median of 163.33)
GF Value™: ₹1,927.98 vs. price of ₹1,973.50 (2.4% above fair value)
Industry Position: 164.8% above the Drug Manufacturers median (#128 of 926)
No single metric tells the full story. See the BOM:524715 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sun Pharmaceuticals Industries Business Description
Sun Pharmaceuticals Industries Ltd is India's generic pharmaceutical manufacturing company. The company's substantial markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is majorly based in India.
92GF Score
Get the complete analysis for BOM:524715
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524715 has been successfully added to your 
